Shares in the digital therapeutics (DTx) developer closed up more than 17% after its debut on the NYSE at $32 under the HNGE ...

To remain relevant in an interconnected ecosystem, biopharma must go beyond optimising yesterday’s markets and begin ...

AstraZeneca has turned to another digital health partner to support its aspirations in chronic kidney disease (CKD), joining ...

The $8-per-share deal will give Sanofi control of Vigil's VG-3927, an oral drug candidate for Alzheimer's that acts as an ...

NICE is also looking at the role of Hympavzi in treating severe haemophilia A, where there are other subcutaneous options ...

According to the CDC, cases of myocarditis and pericarditis are rare with the vaccines and, in most cases, resolve within a ...

For J&J, there was a positive outcome as the Oncologic Drugs Advisory Committee (ODAC) voted six to two in favour of approval ...

Castor bean tick (Ixodes ricinus) female from Hochholz-Kapellenbruch, Germany. There is currently no approved treatment for intracerebral haemorrhagic (ICH) stroke, but Belgian start-up Bioxodes ...

Robert F Kennedy Jr has launched a project to trawl federal databases to try to identify why there has been an increase in diagnoses of autism, but there are deep concerns about the project's ...

Swiss start-up Granite Bio has carved out $100 million in a pair of financings for its pipeline of potentially first-in-class antibodies for autoimmune diseases. The Basel-based company has one ...

A new policy from the NIH in the US will cut billions of dollars of funding for research organisations and hospitals outside the US, in another signal of America's retreat from the world stage.

Sickle cell disease (SCD) affects an estimated 20 million people worldwide. As a genetic condition that leads to severe, lifelong complications, SCD remains a significant unmet medical need with ...